EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineering BHK-21 cells by dual knockout of host-restriction factors Cav1 and HDAC6 achieved a marked increase in FMDV titers for scalable vaccine production

Alka Nokhwal iD, Nitin Khandelwal, Garvit Kumar, Himanshu Kamboj iD, Yogesh Chander iD, Supriya Bhattacharya, Assim Verma, Riyesh T, Sreenivasulu Kilari, Naveen Kumar iD

Journal of Virology · 16.11.2026

DOI: 10.1128/jvi.01164-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, online erschienen am 16.11.2026. Verfasst von Alka Nokhwal und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Veterinary Type Cultures, ICAR-National Research Centre on Equines, Hisar, India. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Foot-and-mouth disease virus (FMDV) vaccine production depends on BHK-21 cells, but the high antigen dose required for biannual mass vaccination campaigns using an inactivated vaccine limits global vaccine supply. In this study, a targeted small-molecule screen identified baicalein (caveolin-1 inhibitor) and tubacin (HDAC6 inhibitor) as potent enhancers of FMDV replication in BHK-21 cells. Cav1 was shown to act as an early restriction factor: its inhibition increased the viral entry and consequently produced a sixfold higher virus yield. Cav1 inhibition also primed p53-dependent intrinsic apoptosis, raising p53 phosphorylation and BAX/BIM transcripts, shifting cells into early apoptosis, and promoting cytolytic spread. HDAC6 was shown to function as a post-entry restriction factor: its inhibition elevated α-tubulin acetylation, enhancing viral RNA and protein expression and producing four to six times titer boost. Finally, using CRISPR/Cas9, we generated Cav1/HDAC6 double-knockout (dKO) BHK-21 cells , targeting two host restriction factors that impose entry and post-entry barriers to FMDV replication. The engineered BHK-21 cells in both adherent and suspension culture formats produced 10- to 20-fold higher virus titers across field FMDV serotype “O” and FMDV vaccine strains of serotypes “O,” “A,” and “Asia 1.” Reintroducing either factor restored restriction, confirming their roles as host restriction factors. These findings reveal a dual-layer host defense mechanism and establish an engineered, high-yield BHK-21 cell line for enhanced viral production and improved vaccine manufacturing efficiency. IMPORTANCE Foot-and-mouth disease (FMD) imposes substantial economic losses on livestock-producing countries through reduced animal productivity and trade restrictions. Control relies on biannual herd vaccination, generating a demand for vaccine that often exceeds current manufacturing capacity. FMD vaccine antigen is conventionally produced in BHK-21 cells; however, limited viral yields increase production costs and constrain supply. Here, we identify caveolin-1 and HDAC6 as host restriction factors for foot-and-mouth disease virus (FMDV) in BHK-21 cells. Caveolin-1 restricts FMDV at the entry stage, whereas HDAC6 acts at a post-entry step. Knockout of these factors enhances viral yields by 10- to 20-fold across FMDV serotypes O, A, and Asia 1—the three serotypes included in India’s trivalent vaccine program. These findings indicate that BHK-21 cells deficient in caveolin-1 and HDAC6 could substantially improve FMDV propagation and provide a scalable, cost-effective platform for vaccine manufacturing.

Schlagwörter

Stichwörter der Autor:innen

Cav1Caveolin-1FMDVHDAC6enhanced viral titerhistone deacetylase 6host-restriction factorp53α-tubulin

Autor:innen und Institutionen

  • National Centre for Veterinary Type Cultures, ICAR-National Research Centre on Equines, Hisar, India.
  • Biovet Pvt Ltd, Pune, India.
  • ICMR-National Institute of Virology, Pune, India.

ORCID-Profile: Alka Nokhwal, Himanshu Kamboj, Yogesh Chander, Naveen Kumar

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Nokhwal, A., Khandelwal, N., Kumar, G., Kamboj, H., Chander, Y., Bhattacharya, S., Verma, A., T, R., Kilari, S., & Kumar, N. (2026). Engineering BHK-21 cells by dual knockout of host-restriction factors Cav1 and HDAC6 achieved a marked increase in FMDV titers for scalable vaccine production. Journal of Virology. https://doi.org/10.1128/jvi.01164-26

Vancouver

Nokhwal A, Khandelwal N, Kumar G, Kamboj H, Chander Y, Bhattacharya S, et al. Engineering BHK-21 cells by dual knockout of host-restriction factors Cav1 and HDAC6 achieved a marked increase in FMDV titers for scalable vaccine production. Journal of Virology. 2026. doi:10.1128/jvi.01164-26

BibTeX
@article{Nokhwal2026,
  author = {Nokhwal, Alka and Khandelwal, Nitin and Kumar, Garvit and Kamboj, Himanshu and Chander, Yogesh and Bhattacharya, Supriya and Verma, Assim and T, Riyesh and Kilari, Sreenivasulu and Kumar, Naveen},
  title = {Engineering BHK-21 cells by dual knockout of host-restriction factors Cav1 and HDAC6 achieved a marked increase in FMDV titers for scalable vaccine production},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.01164-26}
}
Kostenlos starten →